nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—schizophrenia	0.401	0.468	CbGaD
Pomalidomide—CYP1A2—schizophrenia	0.294	0.343	CbGaD
Pomalidomide—ABCB1—schizophrenia	0.162	0.189	CbGaD
Pomalidomide—TNF—blood—schizophrenia	0.00443	0.0905	CbGeAlD
Pomalidomide—CYP1A2—urine—schizophrenia	0.00364	0.0744	CbGeAlD
Pomalidomide—CRBN—forebrain—schizophrenia	0.00317	0.0647	CbGeAlD
Pomalidomide—CRBN—telencephalon—schizophrenia	0.00291	0.0595	CbGeAlD
Pomalidomide—CYP3A4—urine—schizophrenia	0.00264	0.0538	CbGeAlD
Pomalidomide—CRBN—gonad—schizophrenia	0.00243	0.0496	CbGeAlD
Pomalidomide—CRBN—blood—schizophrenia	0.00212	0.0432	CbGeAlD
Pomalidomide—CRBN—midbrain—schizophrenia	0.00209	0.0427	CbGeAlD
Pomalidomide—CYP1A2—blood plasma—schizophrenia	0.0019	0.0388	CbGeAlD
Pomalidomide—Thalidomide—TNF—schizophrenia	0.00187	0.415	CrCbGaD
Pomalidomide—CRBN—endocrine gland—schizophrenia	0.00184	0.0375	CbGeAlD
Pomalidomide—CRBN—nervous system—schizophrenia	0.00172	0.0351	CbGeAlD
Pomalidomide—CRBN—central nervous system—schizophrenia	0.00165	0.0338	CbGeAlD
Pomalidomide—CRBN—cerebellum—schizophrenia	0.00162	0.033	CbGeAlD
Pomalidomide—PTGS2—blood plasma—schizophrenia	0.00157	0.0321	CbGeAlD
Pomalidomide—CYP3A4—blood plasma—schizophrenia	0.00138	0.0281	CbGeAlD
Pomalidomide—Thalidomide—CYP1A2—schizophrenia	0.00137	0.304	CrCbGaD
Pomalidomide—CRBN—brain—schizophrenia	0.00131	0.0268	CbGeAlD
Pomalidomide—Lenalidomide—ABCB1—schizophrenia	0.00126	0.28	CrCbGaD
Pomalidomide—ABCB1—blood plasma—schizophrenia	0.000974	0.0199	CbGeAlD
Pomalidomide—PTGS2—forebrain—schizophrenia	0.000862	0.0176	CbGeAlD
Pomalidomide—PTGS2—telencephalon—schizophrenia	0.000793	0.0162	CbGeAlD
Pomalidomide—CYP1A2—blood—schizophrenia	0.000696	0.0142	CbGeAlD
Pomalidomide—CYP1A2—endocrine gland—schizophrenia	0.000604	0.0123	CbGeAlD
Pomalidomide—PTGS2—blood—schizophrenia	0.000577	0.0118	CbGeAlD
Pomalidomide—PTGS2—midbrain—schizophrenia	0.000569	0.0116	CbGeAlD
Pomalidomide—ABCB1—forebrain—schizophrenia	0.000533	0.0109	CbGeAlD
Pomalidomide—CYP3A4—blood—schizophrenia	0.000504	0.0103	CbGeAlD
Pomalidomide—PTGS2—endocrine gland—schizophrenia	0.0005	0.0102	CbGeAlD
Pomalidomide—ABCB1—telencephalon—schizophrenia	0.00049	0.01	CbGeAlD
Pomalidomide—PTGS2—nervous system—schizophrenia	0.000468	0.00956	CbGeAlD
Pomalidomide—PTGS2—central nervous system—schizophrenia	0.000451	0.0092	CbGeAlD
Pomalidomide—PTGS2—cerebellum—schizophrenia	0.00044	0.009	CbGeAlD
Pomalidomide—CYP3A4—endocrine gland—schizophrenia	0.000437	0.00893	CbGeAlD
Pomalidomide—ABCB1—gonad—schizophrenia	0.000409	0.00836	CbGeAlD
Pomalidomide—CYP3A4—nervous system—schizophrenia	0.000409	0.00835	CbGeAlD
Pomalidomide—CYP3A4—central nervous system—schizophrenia	0.000394	0.00804	CbGeAlD
Pomalidomide—PTGS2—brain—schizophrenia	0.000358	0.00731	CbGeAlD
Pomalidomide—ABCB1—blood—schizophrenia	0.000357	0.00728	CbGeAlD
Pomalidomide—ABCB1—midbrain—schizophrenia	0.000352	0.00719	CbGeAlD
Pomalidomide—ABCB1—endocrine gland—schizophrenia	0.000309	0.00632	CbGeAlD
Pomalidomide—ABCB1—nervous system—schizophrenia	0.00029	0.00591	CbGeAlD
Pomalidomide—ABCB1—central nervous system—schizophrenia	0.000279	0.00569	CbGeAlD
Pomalidomide—ABCB1—cerebellum—schizophrenia	0.000272	0.00556	CbGeAlD
Pomalidomide—ABCB1—brain—schizophrenia	0.000221	0.00452	CbGeAlD
Pomalidomide—TNF—SIDS Susceptibility Pathways—EP300—schizophrenia	6.38e-05	0.000714	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—CYP2D6—schizophrenia	6.36e-05	0.000711	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—HTR3A—schizophrenia	6.33e-05	0.000708	CbGpPWpGaD
Pomalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—schizophrenia	6.33e-05	0.000708	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—AKT1—schizophrenia	6.33e-05	0.000708	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—CYP2D6—schizophrenia	6.27e-05	0.000701	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ACSL6—schizophrenia	6.25e-05	0.000699	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—SLC27A5—schizophrenia	6.25e-05	0.000699	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NDST3—schizophrenia	6.2e-05	0.000693	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MPC2—schizophrenia	5.94e-05	0.000664	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—schizophrenia	5.93e-05	0.000664	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—schizophrenia	5.93e-05	0.000664	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—AKT1—schizophrenia	5.88e-05	0.000658	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—TP53—schizophrenia	5.71e-05	0.000639	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC1A1—schizophrenia	5.64e-05	0.000631	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—schizophrenia	5.62e-05	0.000629	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—EP300—schizophrenia	5.57e-05	0.000623	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	5.54e-05	0.000619	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL1B—schizophrenia	5.52e-05	0.000617	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PLCH2—schizophrenia	5.52e-05	0.000617	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	5.43e-05	0.000607	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—AKT1—schizophrenia	5.42e-05	0.000606	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL1B—schizophrenia	5.39e-05	0.000603	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IPO5—schizophrenia	5.37e-05	0.000601	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—schizophrenia	5.32e-05	0.000595	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—MEF2C—schizophrenia	5.27e-05	0.000589	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NDST3—schizophrenia	5.19e-05	0.00058	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PRODH—schizophrenia	5.16e-05	0.000577	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC17A7—schizophrenia	5.16e-05	0.000577	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—schizophrenia	5.07e-05	0.000568	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—TNF—schizophrenia	5.06e-05	0.000566	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIP4K2A—schizophrenia	5e-05	0.000559	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ACSL6—schizophrenia	4.92e-05	0.00055	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SLC27A5—schizophrenia	4.92e-05	0.00055	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—CYP2D6—schizophrenia	4.91e-05	0.000549	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—CYP2D6—schizophrenia	4.84e-05	0.000541	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—COMT—schizophrenia	4.82e-05	0.000539	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—schizophrenia	4.82e-05	0.000539	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—schizophrenia	4.82e-05	0.000539	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	4.81e-05	0.000538	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—GSTP1—schizophrenia	4.79e-05	0.000536	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—MAOA—schizophrenia	4.78e-05	0.000535	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—COMT—schizophrenia	4.75e-05	0.000531	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—GSTP1—schizophrenia	4.73e-05	0.000529	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—DAO—schizophrenia	4.69e-05	0.000525	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—TP53—schizophrenia	4.59e-05	0.000513	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—GABRB2—schizophrenia	4.58e-05	0.000512	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PNP—schizophrenia	4.5e-05	0.000503	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—CYP1A2—schizophrenia	4.44e-05	0.000496	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—GSTM1—schizophrenia	4.41e-05	0.000493	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—CYP1A2—schizophrenia	4.38e-05	0.000489	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—GSTM1—schizophrenia	4.34e-05	0.000486	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—TP53—schizophrenia	4.3e-05	0.000481	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—AKT1—schizophrenia	4.23e-05	0.000473	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MPC2—schizophrenia	4.21e-05	0.000471	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NDUFV2—schizophrenia	4.18e-05	0.000468	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PRODH—schizophrenia	4.12e-05	0.000461	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TNF—schizophrenia	4.01e-05	0.000448	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—schizophrenia	3.99e-05	0.000446	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC18A2—schizophrenia	3.95e-05	0.000442	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIP4K2A—schizophrenia	3.93e-05	0.00044	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TNF—schizophrenia	3.91e-05	0.000438	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PLCH2—schizophrenia	3.91e-05	0.000438	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	3.9e-05	0.000436	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	3.88e-05	0.000434	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—AKT1—schizophrenia	3.88e-05	0.000434	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—GSK3B—schizophrenia	3.86e-05	0.000431	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	3.79e-05	0.000424	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—COMT—schizophrenia	3.72e-05	0.000416	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GSTP1—schizophrenia	3.7e-05	0.000414	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—MAOA—schizophrenia	3.69e-05	0.000413	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NDST3—schizophrenia	3.68e-05	0.000411	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—COMT—schizophrenia	3.67e-05	0.00041	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—GSTP1—schizophrenia	3.65e-05	0.000408	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC6A1—schizophrenia	3.64e-05	0.000407	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—AKT1—schizophrenia	3.63e-05	0.000406	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP26B1—schizophrenia	3.56e-05	0.000398	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TP53—schizophrenia	3.53e-05	0.000395	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC27A5—schizophrenia	3.49e-05	0.00039	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ACSL6—schizophrenia	3.49e-05	0.00039	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GSTM1—schizophrenia	3.4e-05	0.00038	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—AKT1—schizophrenia	3.36e-05	0.000376	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MPC2—schizophrenia	3.36e-05	0.000376	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	3.36e-05	0.000375	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—GSTM1—schizophrenia	3.35e-05	0.000375	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DAO—schizophrenia	3.33e-05	0.000372	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TLE1—schizophrenia	3.29e-05	0.000368	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NRG3—schizophrenia	3.29e-05	0.000368	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	3.28e-05	0.000367	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ATP2A2—schizophrenia	3.24e-05	0.000362	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PNP—schizophrenia	3.19e-05	0.000357	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PRODH—schizophrenia	3.18e-05	0.000356	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GCLM—schizophrenia	3.17e-05	0.000355	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TPH1—schizophrenia	3.17e-05	0.000355	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	3.13e-05	0.00035	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLCH2—schizophrenia	3.12e-05	0.000349	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TLE3—schizophrenia	3.12e-05	0.000349	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	2.99e-05	0.000334	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PRKD1—schizophrenia	2.98e-05	0.000333	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GAPDH—schizophrenia	2.97e-05	0.000332	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NDUFV2—schizophrenia	2.97e-05	0.000332	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NDST3—schizophrenia	2.94e-05	0.000328	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIP4K2A—schizophrenia	2.79e-05	0.000312	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ACSL6—schizophrenia	2.78e-05	0.000311	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC27A5—schizophrenia	2.78e-05	0.000311	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	2.72e-05	0.000305	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	2.72e-05	0.000304	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DAO—schizophrenia	2.66e-05	0.000297	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FGA—schizophrenia	2.62e-05	0.000293	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MPC2—schizophrenia	2.59e-05	0.00029	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC6A3—schizophrenia	2.59e-05	0.00029	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PNP—schizophrenia	2.55e-05	0.000285	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—EP300—schizophrenia	2.54e-05	0.000284	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP26B1—schizophrenia	2.52e-05	0.000282	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GAPDH—schizophrenia	2.49e-05	0.000278	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CLOCK—schizophrenia	2.47e-05	0.000276	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	2.46e-05	0.000275	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	2.43e-05	0.000272	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLCH2—schizophrenia	2.41e-05	0.00027	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TPH2—schizophrenia	2.4e-05	0.000269	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CACNB2—schizophrenia	2.4e-05	0.000269	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	2.4e-05	0.000269	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	2.38e-05	0.000266	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NDUFV2—schizophrenia	2.37e-05	0.000265	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—DPYD—schizophrenia	2.36e-05	0.000264	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SNAP25—schizophrenia	2.29e-05	0.000256	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NDST3—schizophrenia	2.27e-05	0.000253	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TPH1—schizophrenia	2.25e-05	0.000251	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GCLM—schizophrenia	2.25e-05	0.000251	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIP4K2A—schizophrenia	2.23e-05	0.000249	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CACNA1C—schizophrenia	2.2e-05	0.000246	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ACSL6—schizophrenia	2.15e-05	0.00024	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC27A5—schizophrenia	2.15e-05	0.00024	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3C2A—schizophrenia	2.14e-05	0.000239	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PRKD1—schizophrenia	2.11e-05	0.000236	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HSPA1A—schizophrenia	2.06e-05	0.00023	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DAO—schizophrenia	2.05e-05	0.000229	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS1—schizophrenia	2.04e-05	0.000229	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	2.03e-05	0.000227	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP26B1—schizophrenia	2.01e-05	0.000225	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PNP—schizophrenia	1.97e-05	0.00022	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	1.93e-05	0.000216	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SNAP25—schizophrenia	1.92e-05	0.000215	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP2D6—schizophrenia	1.92e-05	0.000215	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PRL—schizophrenia	1.9e-05	0.000212	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NDUFV2—schizophrenia	1.83e-05	0.000204	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TPH1—schizophrenia	1.79e-05	0.000201	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GCLM—schizophrenia	1.79e-05	0.000201	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GAPDH—schizophrenia	1.76e-05	0.000197	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CLOCK—schizophrenia	1.75e-05	0.000195	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP1A2—schizophrenia	1.74e-05	0.000194	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIP4K2A—schizophrenia	1.72e-05	0.000192	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TH—schizophrenia	1.71e-05	0.000191	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TPH2—schizophrenia	1.7e-05	0.00019	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CACNB2—schizophrenia	1.7e-05	0.00019	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	1.7e-05	0.00019	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	1.69e-05	0.000189	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ERBB4—schizophrenia	1.69e-05	0.000189	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PRKD1—schizophrenia	1.69e-05	0.000189	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DPYD—schizophrenia	1.68e-05	0.000187	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—APOA1—schizophrenia	1.64e-05	0.000183	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NRG1—schizophrenia	1.56e-05	0.000175	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CACNA1C—schizophrenia	1.56e-05	0.000174	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP26B1—schizophrenia	1.55e-05	0.000174	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—AKT1—schizophrenia	1.53e-05	0.000172	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3C2A—schizophrenia	1.52e-05	0.00017	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—YWHAZ—schizophrenia	1.49e-05	0.000167	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ERBB3—schizophrenia	1.46e-05	0.000163	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—COMT—schizophrenia	1.46e-05	0.000163	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTP1—schizophrenia	1.45e-05	0.000162	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MAOA—schizophrenia	1.45e-05	0.000162	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	1.44e-05	0.000161	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GAPDH—schizophrenia	1.41e-05	0.000157	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MTHFR—schizophrenia	1.4e-05	0.000157	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.4e-05	0.000157	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CLOCK—schizophrenia	1.4e-05	0.000156	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	1.39e-05	0.000156	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TPH1—schizophrenia	1.38e-05	0.000155	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GCLM—schizophrenia	1.38e-05	0.000155	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	1.38e-05	0.000154	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCB1—schizophrenia	1.37e-05	0.000153	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2D6—schizophrenia	1.36e-05	0.000152	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SNAP25—schizophrenia	1.36e-05	0.000152	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CACNB2—schizophrenia	1.36e-05	0.000152	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TPH2—schizophrenia	1.36e-05	0.000152	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DPYD—schizophrenia	1.34e-05	0.00015	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PLA2G4A—schizophrenia	1.33e-05	0.000149	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTM1—schizophrenia	1.33e-05	0.000149	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOE—schizophrenia	1.31e-05	0.000146	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PRKD1—schizophrenia	1.3e-05	0.000146	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOA1—schizophrenia	1.29e-05	0.000145	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CACNA1C—schizophrenia	1.24e-05	0.000139	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP1A2—schizophrenia	1.23e-05	0.000138	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TH—schizophrenia	1.21e-05	0.000136	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3C2A—schizophrenia	1.21e-05	0.000136	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MTHFR—schizophrenia	1.18e-05	0.000132	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GSK3B—schizophrenia	1.13e-05	0.000127	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOE—schizophrenia	1.1e-05	0.000123	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2D6—schizophrenia	1.09e-05	0.000122	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SNAP25—schizophrenia	1.09e-05	0.000122	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GAPDH—schizophrenia	1.09e-05	0.000122	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOA1—schizophrenia	1.08e-05	0.000121	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CLOCK—schizophrenia	1.08e-05	0.00012	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TPH2—schizophrenia	1.05e-05	0.000117	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CACNB2—schizophrenia	1.05e-05	0.000117	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DPYD—schizophrenia	1.03e-05	0.000115	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—COMT—schizophrenia	1.03e-05	0.000115	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTP1—schizophrenia	1.03e-05	0.000115	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MAOA—schizophrenia	1.02e-05	0.000115	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TH—schizophrenia	9.69e-06	0.000108	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CACNA1C—schizophrenia	9.6e-06	0.000107	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PLA2G4A—schizophrenia	9.44e-06	0.000106	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTM1—schizophrenia	9.44e-06	0.000106	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3C2A—schizophrenia	9.35e-06	0.000105	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2D6—schizophrenia	8.39e-06	9.38e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SNAP25—schizophrenia	8.39e-06	9.38e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MTHFR—schizophrenia	8.34e-06	9.33e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—COMT—schizophrenia	8.24e-06	9.21e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTP1—schizophrenia	8.2e-06	9.17e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MAOA—schizophrenia	8.18e-06	9.15e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	7.93e-06	8.87e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOE—schizophrenia	7.76e-06	8.68e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCB1—schizophrenia	7.76e-06	8.68e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOA1—schizophrenia	7.68e-06	8.58e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP1A2—schizophrenia	7.59e-06	8.48e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTM1—schizophrenia	7.53e-06	8.43e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLA2G4A—schizophrenia	7.53e-06	8.43e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TH—schizophrenia	7.48e-06	8.36e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—EP300—schizophrenia	7.45e-06	8.34e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MTHFR—schizophrenia	6.66e-06	7.45e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—COMT—schizophrenia	6.36e-06	7.11e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTP1—schizophrenia	6.33e-06	7.08e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MAOA—schizophrenia	6.31e-06	7.06e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—EP300—schizophrenia	6.24e-06	6.98e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOE—schizophrenia	6.2e-06	6.93e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOA1—schizophrenia	6.13e-06	6.85e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCB1—schizophrenia	5.99e-06	6.7e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTM1—schizophrenia	5.81e-06	6.5e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLA2G4A—schizophrenia	5.81e-06	6.5e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MTHFR—schizophrenia	5.14e-06	5.75e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOE—schizophrenia	4.78e-06	5.35e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOA1—schizophrenia	4.73e-06	5.29e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKT1—schizophrenia	4.5e-06	5.04e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—EP300—schizophrenia	4.43e-06	4.95e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AKT1—schizophrenia	3.77e-06	4.22e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—EP300—schizophrenia	3.53e-06	3.95e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—EP300—schizophrenia	2.73e-06	3.05e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AKT1—schizophrenia	2.67e-06	2.99e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AKT1—schizophrenia	2.13e-06	2.39e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKT1—schizophrenia	1.65e-06	1.84e-05	CbGpPWpGaD
